期刊文献+

α-Synuclein蛋白聚集状态与帕金森病形成 被引量:7

Aggregation States of α-Synuclein and Its Involvement in Parkinson’s Disease
在线阅读 下载PDF
导出
摘要 帕金森病是一种常见的老年神经退行性疾病,其致病机理复杂.其中α-synuclein基因是较早发现的与帕金森病相关的基因,其编码的α-synuclein蛋白是帕金森病神经元内出现的一种蛋白包涵体结构——路易体的主要组成成分.最近的研究结果显示,α-synuclein蛋白存在不同聚集状态间的转换,其中聚集过程中形成的寡聚体中间构象具有较强的细胞毒性,可能对帕金森病的发病过程有着重要作用;而且这种聚集状态的转换过程受到多种遗传学与细胞学因素的影响,从而在某种程度上反映了帕金森病发生形成的遗传学与细胞学机制.本文将对α-synuclein蛋白聚集状态转换特性及其在帕金森病发病过程中作用机制方面的研究进展作一综述. Parkinson' s disease (PD) is a wide-spread age-related neurodegeneration disorder with very complex pathological mechanisms, α-Synuclein gene is among the first genes identified to be related to PD and the α-synuclein protein is a major component of protein inclusions called Lewy bodies, whose appearance in the survival dopamine neurons is one of the pathologic hallmarks of PD. α-synuclein has recently been shown to undergo transitions between different aggregation states both in vivo and in vitro, mediated by the readily aggregated propensity of α-synuclein. Among others, an intermediate oligomer configuration called protofibril, has been found to show much stronger cytotoxicity than the insoluble fibril conformation, which is the final form of polymerization normally found in Lewy bodies. In the meantime, quite a few genetic and cellular factors including α-synuclein gene mutation and duplication, lipid metabolism, oxidative stress as well as protein folding and quality control system, have been demonstrated to affect the process of α-synuclein aggregation. These findings are beginning to uncover the underlying mechanisms of the occurrence and development of PD. Herein, we review recent findings on the structural characterization of α-synuclein and exploit the possible molecular and cellular mechanisms involved in the etiopathogenesis of PD.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2006年第8期615-620,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 山东省优秀中青年科学家奖励基金资助项目(2004B302011)~~
关键词 帕金森病 α-synuclein蛋白 蛋白聚集 不饱和脂肪酸 泛素-蛋白酶体 Parkinson' s disease α-synuclein protein aggregation unsaturated fatty acid ubiquitin and proteosome
  • 相关文献

参考文献44

  • 1Lansbury P T Jr,Brice A.Genetics of Parkinson's disease and biochemical studies of implicated gene products[J].Curr Opin Cell Biol,2002,14(5):653-660
  • 2Lotharius J,Brundin P.Pathogenesis of Parkinson's disease:dopamine,vesicles and alpha-synuclein[J].Nat Rev Neurosci,2002,3(12):932-942
  • 3Goldberg M S,Lansbury P T Jr.Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease[J]? Nat Cell Biol,2000,2(7):E115-E119
  • 4Goedert M.Alpha-synuclein and neurodegenerative diseases[J].Nat Rev Neurosci,2001,2(7):492-501
  • 5Dawson T M,Dawson V L.Rare genetic mutations shed light on the pathogenesis of Parkinson disease[J].J Clin Invest,2003,111(2):145-151
  • 6Masliah E,Rockenstein E,Veinbergs I,et al.Dopaminergic loss and inclusion body formation in alpha-synuclein mice:implications for neurodegenerative disorders[J].Science,2000,287 (5456):1265-1269
  • 7Kuwahara T,Koyama A,Gengyo-Ando K,et al.Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans[J].J Biol Chem,2006,281(1):334-340
  • 8Kessler J C,Rochet J C,Lansbury P T Jr.The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation[J].Biochemistry,2003,42(3):672-678
  • 9Perrin R J,Woods W S,Clayton D F,et al.Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins[J].J Biol Chem,2001,276(45):41958-41962
  • 10Souza J M,Giasson B I,Lee V M,et al.Chaperote-like activity of synucleins[J].FEBS Lett,2000,474(1):116-119

同被引文献119

  • 1张松龄,唐宏.自体吞噬——Ⅱ型程序性死亡[J].生物化学与生物物理进展,2005,32(11):1011-1015. 被引量:6
  • 2邢永红,张本恕,安中平.磁共振测量海马体积在帕金森病中的应用[J].国外医学(老年医学分册),2007,28(2):80-83. 被引量:2
  • 3谷丽梅,张朝东.血清泌乳素水平与帕金森病痴呆的相关性研究[J].中风与神经疾病杂志,2007,24(3):291-293. 被引量:2
  • 4Cohen P. The hormonal control of glycogen metabolism in mammalian muscle by muhivalent phosphorylation [ J ]. Biochem Soc Trans, 1979, 7(3) :459-480.
  • 5Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A [J].EMBO J, 1990, 9(8) :2431-2438.
  • 6Woodgett JR. cDNA cloning and properties of glycogen synthase kinase-3[J] .Method Enzymol, 1991,200:564-577.
  • 7Leroy K, Brion JP. Developmental expression and localization of glycogen synthase kinase-3β in rat brain [ J]. J Chem Neuroanat, 1991, 16:279-293.
  • 8Koh SH, Lee YB, Kim K S, et al. Role of GSK-3β activity in motor neuronal cell death induced by G95A or A4V mutant hSOD1 gene [J]. Eur J Neurosci, 2005, 22(2) :301-309.
  • 9Koh SH, Roh H, Lee SM, et al. Phosphatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene [J]. Toxicology, 2005, 213(1-2):45-55.
  • 10Watcharasit P, Bijur GN, Song L, et al. Glycogen synthase kinase - 3β (GSKβ) binds to and promotes the actions of p53 [ J]. J BiolChem,2003, 278(49) :48872-48879.

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部